BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 309061)

  • 1. [Long term effects of splenectomy on the immune-status of Hodgkin's disease patients depending on the modality of treatment (author's transl)].
    Schaadt M; Diehl V; Kalden JR; Schmidt N; Laskewitz E
    Med Klin; 1978 Oct; 73(40):1381-8. PubMed ID: 309061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
    Pluzańska A
    Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term influence of splenectomy on immune functions in patients with Hodgkin's disease.
    Björkholm M; Askergren J; Holm G; Mellstedt H
    Scand J Haematol; 1980 Jan; 24(1):87-94. PubMed ID: 6966069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The bone marrow in Hodgkin's disease following radiotherapy and splenectomy].
    Baĭsogolov GD; Pavlov VV; Bogatyreva TI; Khait SE; Kuz'mina EG
    Med Radiol (Mosk); 1987 May; 32(5):3-7. PubMed ID: 3586920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
    Karande AA; Gulwani B; Advani SH; Gangal SG
    Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.
    Gajl-Peczalska KJ; Bloomfield CD; Sosin H; Kersey JH
    Clin Exp Immunol; 1976 Jan; 23(1):47-55. PubMed ID: 1083318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
    Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
    J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of radiochemotherapy and splenectomy on lymphoid subclasses in patients with Hodgkin's lymphoma in complete remission].
    Leoni P; Montroni M; Montillo M; Salvi A; Centurioni R; Fanciulli E
    G Clin Med; 1981 Oct; 62(10):685-92. PubMed ID: 6977469
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunglobulins G, A, M, and E in lymphogranulomatosis (author's transl)].
    Steidle C; Fateh-Moghadam A; Lamerz R; Huhn D; Ehrhart H
    MMW Munch Med Wochenschr; 1976 Apr; 118(16):503-8. PubMed ID: 818517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological data in the clinical evaluation of Hodgkin's diseases].
    Burchardt K
    Z Gesamte Inn Med; 1981 Nov; 36(21):840. PubMed ID: 6977241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of advanced Hodgkin's disease in remission.
    Klener P; Hausner P; Donner L
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):213-7. PubMed ID: 6179821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
    Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired humoral immunity in treated Hodgkin's disease.
    Weitzman SA; Aisenberg AC; Siber GR; Smith DH
    N Engl J Med; 1977 Aug; 297(5):245-8. PubMed ID: 301608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
    Pappas A; Pees H; Girmann G
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levamisole in the treatment of Hodgkin's disease.
    Berényi E; Kávai M; Szabolcsi M; Szegedi G
    Acta Med Acad Sci Hung; 1979; 36(2):177-85. PubMed ID: 317549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.